One year of impact—and we’re just getting started. The National Triglyceride Alliance was founded on a simple idea: triglycerides deserve more attention as a critical driver of cardiovascular and metabolic health. Since then? ✔️ A growing national coalition ✔️ New education and clinical resources ✔️ Expanded awareness for patients and providers As we approach #NationalTriglyceridesDay (March 28), we’re reminded that progress starts with awareness—and continues with action. Let’s keep pushing forward. Read the press release: ow.ly/NPoz50YwlrN @SethJBaumMD @EliotBrinton @mmillermd1 @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @ASPCardio @NatPancFdn @livingwithfcs @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp #Triglycerides #Cardiology #MedEd #HealthcareInnovation

🙌 Today the 2026 ACC/AHA Guideline on the Management of Dyslipidemia has been released. 📍Key updates shaping contemporary lipid management: 1️⃣ Lp(a) measurement is now recommended at least once in all adults for ASCVD risk assessment. 2️⃣ PREVENT equations replace the Pooled Cohort Equations for estimating 10-year and 30-year ASCVD risk. 3️⃣ LDL-C and non-HDL-C treatment goals return as central therapeutic targets alongside percentage LDL reduction. 4️⃣ Earlier intervention is emphasized to reduce lifelong exposure to atherogenic lipoproteins. 5️⃣ Broader integration of ApoB, CAC scoring, and modern lipid-lowering therapies to refine risk stratification and treatment. 👆 An important step forward in translating decades of lipid research into clinical practice and cardiovascular prevention. 🔓 Open Access 🔗 jacc.org/doi/10.1016/j.jacc.… @nationallipid @society_eas

The 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia is here, and the NLA is proud to be among the collaborating organizations. This landmark guideline addresses evaluation, management, and monitoring of elevated cholesterol, triglycerides, and Lp(a); restores LDL-C treatment goals based on risk; and provides guidance for both adults and children across all stages of prevention. Read the full guideline: jacc.org/doi/10.1016/j.jacc.… Read the NLA's press release: lipid.org/nla/2026-accahamul… #Lipidology #Dyslipidemia #Cholesterol #CardiovascularHealth

Great to share the podium @PriMedCME with my friend ,colleague , mentor and yes my PGY2 when I was an intern @BellevueHosp - and past president @nationallipid Dr Terry Jacobson - great to catch up ! @BHLipidclinic @NYUCVDPrevent

This is a wonderful program on Lipoprotein(a) Still time to register ! Happy to share @ArchnaBajajMD @PennMedicine @nationallipid @foundationofnla @FamilyHeartFdn @NYUCVDPrevent

This Rare Disease Month, we’re cheering for patients on and off the field. And, tailgating the big game doesn’t have to mean high fat.🏈 Our new Buffalo Chicken Dip is low fat but still packed with flavor. So, everyone wins, no matter which team you’re cheering for!😉

Our annual ONLINE Foundations in Lipidology course is almost here!🧑‍💻 Join us in just two weeks (Feb. 16–17) for this premier introductory program designed for healthcare professionals looking to build a strong foundation in lipid management. Led by experts in clinical lipidology, this course is a must-attend for anyone entering or advancing in the field. 🔗Register now: lipid.org/foundations

Excited to see this now available ! Please share @nationallipid @foundationofnla @FamilyHeartFdn @NYUCVDPrevent @Drlipid

Join us Feb 4 for Heart Month ❤️ With the FDA’s recent removal of the black box warning on many HRTs, it’s normal to have questions about safety and heart impact. Hear NYU experts discuss hormones and women’s #HeartHealth in this free webinar. 🔗 i.nyulangone.org/h7v

LIB Therapeutics announced the FDA has approved LEROCHOL™ (lerodalcibep-liga), a novel third-generation PCSK9 inhibitor injection for subcutaneous use as an adjunct to diet and exercise to reduce LDL-C in adults with hypercholesterolemia, including HeFH. To read more: libtherapeutics.com/news-and…

The NLA is proud to provide a new CME activity designed for dermatologists focused on recognizing and managing lipodystrophy. Participants will learn to: 🩺 Identify key physical signs of lipodystrophy in diverse patients 🔍 Apply effective screening and referral techniques 🤝 Strengthen collaboration across the healthcare team We’re excited to help more clinicians recognize lipodystrophy earlier and connect patients to the specialized care they need. Know someone who might benefit? Share this link: ow.ly/F2gm50XuMGf

#Lipidologists: Are you aware of the new ICD-10 codes for FH? Stay informed and make sure your practice is coding correctly! #KnowFH

Another option for patients with #FCS 🙌 @NYUCVDPrevent @livingwithfcs @foundationofnla

FDA approves @ArrowheadPharma therapy to lower triglycerides in adults with familial chylomicronemia syndrome (#FCS). A major milestone for the care of #FCS patients. Learn More: ir.arrowheadpharma.com/news-… #FCS #RareDisease #FDAApproval @SethJBaumMD @EliotBrinton @lipiddoc @ArchnaBajajMD @drmaggarwal @NatPancFdn @ASPCardio @NatPancFdn @livingwithfcs @TheAACE @HeartNurses @ArrowheadPharma

Hypertension can often go undetected. Our Center offers specialized #bloodpressure monitoring and personalized plans to help you take control, preventing the risk of heart disease and heart failure. Learn more: nyulangone.org/care-services…

Great CME program Oct 10th. Sign up now ! @nyulangone @NYUCVDPrevent

#LowerIsBetter #VesaliusCV Exciting news! Looking forward to seeing the full results at #AHA25 @FamilyHeartFdn @nationallipid @ABCardio1 @ASPCardio @advcardiohealth @NatForumHDSP @ACCinTouch @SethJBaumMD @DrMarthaGulati @YHandelsmanMD @lipiddoc @Drlipid @PeterAttiaMD

📉Lower LDL-C for longer is better. The NLA’s new guidance simplifies LDL-C management for adults — helping clinicians & patients improve evidence-based measurement and treatment of LDL-C. Read the guidelines & recommendations: lipidjournal.com/article/S19…. @LipidCNS @CBallantyneMD

Very excited to welcome our new Fellow! #Lipids #LipidologistInTraining 16 Lipid specialists so far , #17 on the way ! As my good friend and colleague @DrLipid always says- Happy Lipiding ! @NYUCVDPrevent @nationallipid